サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1722845

持続グルコースモニタリングシステムの市場規模、シェア、動向、予測：コンポーネント、人口統計、エンドユーザー、地域別、2025-2033年

Continuous Glucose Monitoring Systems Market Size, Share, Trends and Forecast by Component, Demographics, End User, and Region, 2025-2033

出版日
発行
IMARC
ページ情報
英文 143 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.36円
持続グルコースモニタリングシステムの市場規模、シェア、動向、予測：コンポーネント、人口統計、エンドユーザー、地域別、2025-2033年
出版日: 2025年05月01日
発行: IMARC
ページ情報: 英文 143 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の持続グルコースモニタリングシステムの市場規模は2024年に70億4,000万米ドルとなりました。今後、IMARC Groupは、同市場が2033年までに109億2,000万米ドルに達し、2025年から2033年にかけて4.75%のCAGRを示すと予測しています。現在、北米が市場を独占しており、2024年には38.7%以上の市場シェアを占める。CGMデバイスの認知度向上と採用、糖尿病有病率の上昇、CGMデバイスの大幅な技術進歩、予防ヘルスケアへの継続的なシフトなどが、持続グルコースモニタリングシステムの市場シェアを押し上げる要因となっています。

持続グルコースモニタリングシステムの（CGMS）は、血糖値を自動的に追跡する技術的に高度なデバイスです。トランスミッター一体型センサーで構成され、経皮または皮下ルートで機能し、間質液中のグルコース濃度を継続的に測定します。トランスミッターは、その情報を衣服に装着可能なワイヤレスモニターに送信します。持続グルコースモニタリングシステムのは、糖尿病の完全なプロファイルを提供し、血糖値の高低を警告し、パターンを検出し、身体活動、薬の選択、食事の量、ストレスに関する患者の洞察を深めるのに役立ちます。従来のグルコースモニタリング装置と比較して、CGMSは皮膚の上に置くことができるため刺す必要がなく、迅速で痛みのない方法でリアルタイムの情報を提供するのに役立ちます。

持続グルコースモニタリングシステムの市場動向：

糖尿病を開拓しやすい老年人口が世界中で増加していることが、市場に明るい展望をもたらしています。CGMSは一般的に体内のグルコースとインスリンのレベルを測定するために使用され、危険なレベルまで低下したり上昇したりするとアラームが鳴る。これに伴い、低血糖や高血糖の状況をリアルタイムで特定するために製品が広く利用されていることが、市場の成長を後押ししています。さらに、糖尿病患者の糖化ヘモグロビン（Hb1ac）の検出を支援するCGMSの大幅な改良と新技術の進歩が、市場の成長を大幅に後押ししています。さらに、人工膵臓装置システムとCGMS技術の統合により、患者の血糖値を管理するためにインスリンを汲み上げ、最適な投与量を投与することが、市場成長にプラスの影響を与えています。これとは別に、便利な代替手段としての非侵襲的なCGMSデバイスの導入、広範な研究開発（R&D）活動、低侵襲または低侵襲の診断ツールに対する需要の高まりは、市場のさらなる成長に向けた原動力になると予想されます。

本レポートで扱う主な質問

  • 持続グルコースモニタリングシステムの市場の規模は？
  • 持続グルコースモニタリングシステムの市場の将来展望は？
  • 持続グルコースモニタリングシステムの市場を牽引する主要因は何か？
  • 持続グルコースモニタリングシステムの市場で最大のシェアを占める地域は？
  • 世界の持続グルコースモニタリングシステムの市場における主要企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の持続グルコースモニタリングシステムの市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：コンポーネント別

  • センサー
  • 送信機と受信機
  • 一体型インスリンポンプ

第7章 市場内訳：人口統計別

  • 児童人口（<=14 years）
  • 成人人口（14歳以上）

第8章 市場内訳：エンドユーザー別

  • クリニックと診断センター
  • 集中治療室
  • 在宅ヘルスケア

第9章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場内訳：国別

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • A. Menarini Diagnostics S.r.l.
    • Abbott Laboratories
    • DexCom Inc.
    • F. Hoffmann-La Roche AG
    • Glysens Incorporated
    • LifeScan Inc.（Johnson & Johnson）
    • Medtronic PLC
    • Medtrum Technologies Inc.
    • Nemaura Medical Inc.
    • Novo Nordisk A/S
    • Senseonics Holdings Inc.
    • Waveform Technologies Inc.
図表

List of Figures

  • Figure 1: Global: Continuous Glucose Monitoring Systems Market: Major Drivers and Challenges
  • Figure 2: Global: Continuous Glucose Monitoring Systems Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Continuous Glucose Monitoring Systems Market: Breakup by Component (in %), 2024
  • Figure 5: Global: Continuous Glucose Monitoring Systems Market: Breakup by Demographics (in %), 2024
  • Figure 6: Global: Continuous Glucose Monitoring Systems Market: Breakup by End User (in %), 2024
  • Figure 7: Global: Continuous Glucose Monitoring Systems Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Continuous Glucose Monitoring Systems (Sensors) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Continuous Glucose Monitoring Systems (Sensors) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Continuous Glucose Monitoring Systems (Transmitters and Receivers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Continuous Glucose Monitoring Systems (Transmitters and Receivers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Continuous Glucose Monitoring Systems (Integrated Insulin Pumps) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Continuous Glucose Monitoring Systems (Integrated Insulin Pumps) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Continuous Glucose Monitoring Systems (Child Population (<=14 years)) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Continuous Glucose Monitoring Systems (Child Population (<=14 years)) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Continuous Glucose Monitoring Systems (Adult Population (>14 years)) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Continuous Glucose Monitoring Systems (Adult Population (>14 years)) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Continuous Glucose Monitoring Systems (Clinics and Diagnostics Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Continuous Glucose Monitoring Systems (Clinics and Diagnostics Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Continuous Glucose Monitoring Systems (ICUs) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Continuous Glucose Monitoring Systems (ICUs) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Continuous Glucose Monitoring Systems (Home Healthcare) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Continuous Glucose Monitoring Systems (Home Healthcare) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: North America: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: North America: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: United States: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: United States: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Canada: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Canada: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Asia-Pacific: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Asia-Pacific: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: China: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: China: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Japan: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Japan: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: India: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: India: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: South Korea: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: South Korea: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Australia: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Australia: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Indonesia: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Indonesia: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Others: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Others: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Europe: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Europe: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Germany: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Germany: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: France: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: France: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: United Kingdom: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: United Kingdom: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Italy: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Italy: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Spain: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Spain: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Russia: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Russia: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Others: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Others: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Latin America: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Latin America: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Brazil: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Brazil: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Mexico: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Mexico: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Others: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Others: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Middle East and Africa: Continuous Glucose Monitoring Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Middle East and Africa: Continuous Glucose Monitoring Systems Market: Breakup by Country (in %), 2024
  • Figure 72: Middle East and Africa: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Global: Continuous Glucose Monitoring Systems Industry: SWOT Analysis
  • Figure 74: Global: Continuous Glucose Monitoring Systems Industry: Value Chain Analysis
  • Figure 75: Global: Continuous Glucose Monitoring Systems Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Continuous Glucose Monitoring Systems Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Continuous Glucose Monitoring Systems Market Forecast: Breakup by Component (in Million USD), 2025-2033
  • Table 3: Global: Continuous Glucose Monitoring Systems Market Forecast: Breakup by Demographics (in Million USD), 2025-2033
  • Table 4: Global: Continuous Glucose Monitoring Systems Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 5: Global: Continuous Glucose Monitoring Systems Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Continuous Glucose Monitoring Systems Market: Competitive Structure
  • Table 7: Global: Continuous Glucose Monitoring Systems Market: Key Players
目次
Product Code: SR112025A5377

The global continuous glucose monitoring systems market size was valued at USD 7.04 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 10.92 Billion by 2033, exhibiting a CAGR of 4.75% from 2025-2033. North America currently dominates the market, holding a market share of over 38.7% in 2024. The increasing awareness and adoption of CGM devices, rising prevalence of diabetes, significant technological advancements in CGM devices, and ongoing shift towards preventive healthcare are some of the factors boosting the continuous glucose monitoring systems market share.

Continuous glucose monitoring systems (CGMS) are technologically advanced devices that automatically track blood glucose levels. They consist of a transmitter-integrated sensor that functions through a transcutaneous or subcutaneous route to continuously measure the glucose concentration in interstitial fluid. The transmitter then sends the information to a wireless monitor that can be clipped to clothes. Continuous glucose monitoring systems assist in providing a complete profile of diabetes, alerting highs and lows of blood sugar levels, detecting patterns, and increasing patient insights regarding physical activity, medication choices, food portions and stress. As compared to conventional glucose monitoring devices, CGMS are prick-free as they can be placed over the skin, thus aiding in providing real-time information in a quick and painless fashion.

Continuous Glucose Monitoring Systems Market Trends:

The rising geriatric population across the globe that are more susceptible to developing diabetes is creating a positive outlook for the market. CGMS is commonly used for measuring glucose and insulin level in the body, which further sounds an alarm if it drops or rises to a dangerous level. In line with this, the widespread product utilization to identify hypoglycemia and hyperglycemic situations in real-time is favoring the market growth. Moreover, significant improvements and new technological advancements in CGMS that aid in detecting glycated hemoglobin (Hb1ac) in patients with diabetes are providing a considerable boost to the market growth. Additionally, the integration of artificial pancreas device systems with CGMS technology to pump insulin and administer optimum dosage to manage the blood sugar levels of patients is positively impacting the market growth. Apart from this, the introduction of non-invasive CGMS devices as a convenient alternative, extensive research and development (R&D) activities and the increasing demand for less or minimally invasive diagnostic tools are anticipated to drive the market further toward growth.

Key Market Segmentation:

Breakup by Component:

  • Sensors
  • Transmitters and Receivers
  • Integrated Insulin Pumps

Breakup by Demographics:

  • Child Population (<=14 years)
  • Adult Population (>14 years)

Breakup by End User:

  • Clinics and Diagnostics Centers
  • ICUs
  • Home Healthcare

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being A. Menarini Diagnostics S.r.l., Abbott Laboratories, DexCom Inc., F. Hoffmann-La Roche AG, Glysens Incorporated, LifeScan Inc. (Johnson & Johnson), Medtronic PLC, Medtrum Technologies Inc., Nemaura Medical Inc., Novo Nordisk A/S, Senseonics Holdings Inc. and Waveform Technologies Inc.

Key Questions Answered in This Report

  • 1.How big is the continuous glucose monitoring systems market?
  • 2.What is the future outlook of continuous glucose monitoring systems market?
  • 3.What are the key factors driving the continuous glucose monitoring systems market?
  • 4.Which region accounts for the largest continuous glucose monitoring systems market share?
  • 5.Which are the leading companies in the global continuous glucose monitoring systems market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Continuous Glucose Monitoring Systems Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Component

  • 6.1 Sensors
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Transmitters and Receivers
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Integrated Insulin Pumps
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Demographics

  • 7.1 Child Population (<=14 years)
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Adult Population (>14 years)
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Clinics and Diagnostics Centers
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 ICUs
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Home Healthcare
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 A. Menarini Diagnostics S.r.l.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Abbott Laboratories
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 DexCom Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 F. Hoffmann-La Roche AG
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 Glysens Incorporated
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 LifeScan Inc. (Johnson & Johnson)
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 SWOT Analysis
    • 14.3.7 Medtronic PLC
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Medtrum Technologies Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Nemaura Medical Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
    • 14.3.10 Novo Nordisk A/S
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Senseonics Holdings Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
    • 14.3.12 Waveform Technologies Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio